Evidence map›Paper›PMID 36678039›Full record

ArticleNanomaterials (Basel, Switzerland)2023

Rossella Migliore, Loredana Ferreri, Danilo Aleo, Claudia Giovanna Leotta, Giovanni Mario Pitari, Nicola D'Antona, Carmelo Sgarlata, Grazia Maria Letizia Consoli

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Rossella MiglioreInstitute of Biomolecular Chemistry-National Research Council (C.N.R.), Via Paolo Gaifami 18, 95126 Catania, Italy.
Loredana FerreriInstitute of Biomolecular Chemistry-National Research Council (C.N.R.), Via Paolo Gaifami 18, 95126 Catania, Italy.
Danilo AleoMEDIVIS Srl, Via Carnazza 34C, Tremestieri Etneo, 95030 Catania, Italy.
Claudia Giovanna LeottaVera Salus Ricerca, Via Sigmund Freud 62/B, 96100 Siracusa, Italy.
Giovanni Mario PitariVera Salus Ricerca, Via Sigmund Freud 62/B, 96100 Siracusa, Italy.ORCID 0000-0003-0698-8112
Nicola D'AntonaInstitute of Biomolecular Chemistry-National Research Council (C.N.R.), Via Paolo Gaifami 18, 95126 Catania, Italy.ORCID 0000-0002-1711-8262
Carmelo SgarlataDepartment of Chemical Sciences, University of Catania, Viale Andrea Doria 6, 95125 Catania, Italy.ORCID 0000-0002-9284-1303
Grazia Maria Letizia ConsoliInstitute of Biomolecular Chemistry-National Research Council (C.N.R.), Via Paolo Gaifami 18, 95126 Catania, Italy.ORCID 0000-0002-9608-5138
National Research Council · ITMedivis (Italy) · ITUniversity of Catania · IT

Funding

Ministero dell'Istruzione, dell'Università e della Ricerca PRIN 2015MP34H3PO FESR 2014-2020, Action 1.1.5, NUSTEO CUP: 551 G68I18000700007 - application code 08CT2120090065Università di Catania Piaceri 2020-22, linea 2
6 · The paper itself

Abstract

Povidone iodine (PVPI) is an antiseptic widely used against a broad spectrum of pathogens. However, undesired side-effects are still associated with PVPI treatment due to the irritant effect of iodine. Reducing the concentration of a PVPI formulation could provide safer and more friendly formulations, for routine use and applications in very delicate organs such as the eye. However, managing the storage of a low-concentration solution of PVPI is challenging due to the high iodine volatility. In this study, we demonstrated that an amphiphilic

Indexed as

antibacterial activitymicellar aggregatenon-covalent interactionspovidone-iodinesulfonato-calix[4]arene

Identifiers

PMID36678039
PMCPMC9865561
OpenAlexW4315648032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.